Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test

The genomic landscape of metastatic castration-resistant prostate cancer (mCRPC) differs from that of the primary tumor and is dynamic during tumor progression. The real-time and repeated characterization of this process via conventional solid tumor biopsies is challenging. Alternatively, circulatin...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Billalabeitia, Enrique, Conteduca, Vincenza, Wetterskog, Daniel, Jayaram, Anuradha, Attard, Gerhardt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398580/
https://www.ncbi.nlm.nih.gov/pubmed/30413805
http://dx.doi.org/10.1038/s41391-018-0098-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398580/
https://www.ncbi.nlm.nih.gov/pubmed/30413805
http://dx.doi.org/10.1038/s41391-018-0098-x

Ejemplares similares